Modification of oxidative status in Plasmodium berghei-infected erythrocytes by E-2-chloro-8-methyl-3-[(4'-methoxy-1'-indanoyl)-2'-methyliden]-quinoline compared to chloroquine

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 865-870

  Rodrigues, Juan ^a   Charris, Jaime ^a   Domínguez, José ^a   Ángel, Jorge ^b   Gamboa, Neira ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b FACULTAD DE CIENCIAS VETERINARIAS   (Venezuela)

Author keywords

Haemoglobin degradation; Malaria; Oxidative stress; Quinoline

Indexed keywords

PLASMODIUM BERGHEI; PLASMODIUM PARASITES;

EID: 70350273410     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000600008     Document Type: Article

References (43)

1. Aebi H 1984. Catalase in vitro. Methods Enzymol 103: 121-126.
2. Atamna H, Ginsburg H 1993. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 61: 231-241.
3. Atamna H, Ginsburg H 2005. Heme degradation in the presence of glutathione. J Biol Chem 27: 24876-24883.
4. Becker K, Tilley L, Vennerstrom DR, Rogerson S, Ginsburg H 2004. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34: 163-189.
5. Bendrat K, Berger BJ, Cerami A 1995. Haem polymerization in malaria. Nature 378: 138.
6. Bergmeyer HU, Gawehn K, Grassl M 1974. Glucose-6-phosphate dehydrogenase. In HU Bergmeyer, Methods of enzymatic analysis, Academic Press, New York, p. 458-459.
7. Bernt E, Bergmeyer HU 1974. Isocitrate dehydrogenase. In HU Bergmeyer, Methods of enzymatic analysis, Academic Press, New York, p. 624-631.
8. Bhatia Am, Charet P 1984. Action of chloroquine on glutathione metabolism in erythrocytes parasitized by Plasmodium berghei. Ann Parasitol Hum Comp 59: 317-320.
9. Buege JA, Aust SD 1978. Microsomal lipid peroxidation. Methods Enzymol 52C: 302-310.
10. Charris J, Domínguez JN, Gamboa N, Rodrigues J, Angel J 2005. Synthesis and antimalarial activity of E-2-quinolinylbenzocy-cloalcanones. Eur J Med Chem 40: 875-881.
11. Chong CR, Sullivan DJ Jr 2003. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem Pharmacol 66: 2201-2212.
12. Cotton DWK, Sutorius AHM 1971. Inhibiting effect of some antimalarial substances on glucose-6-phosphate dehydrogenase. Nature 233: 197.
13. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R, Hardeman MR, Kager PA, Vreeken J, White NJ 1999. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg 60: 733-737.
14. Farombi EO, Shyntum YY, Emerole GO 2003. Influence of chloroquine treatment and Plasmodium falciparum malaria infection on some enzymatic and non-enzymatic antioxidant defense indices in humans. Drug Chem Toxicol 26: 59-71.
15. Flohé L, Günzler WA 1984. Assays of glutathione peroxidase. Methods Enzymol 77: 398-404.
16. Francis SE, Sullivan DJ Jr, Goldberg DE 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51: 97-123.
17. Gamboa ND, Rosenthal P 1996. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood 87: 4448-4454.
18. Ginsburg H, Atamna H 1994. The redox status of malaria-infected erythrocytes: an overview with an emphasis on unresolved problems. Parasite 1: 5-13.
19. Goldberg DE, Slater AF, Cerami A, Henderson GB 1990. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA 87: 2931-2935.
20. Habig WH, Pabst MJ, Jakoby WB 1974. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
21. Ittarat W, Sreepian A, Srisarin A, Pathepchotivong K 2003. Effect of dihydroartemisinin on the antioxidant capacity of P. falciparum-infected erythrocytes. Southeast Asian J Trop Med Public Health 34: 755-750.
22. Jackson MJ, Jones DA, Harris EJ 1984. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors. Biosci Rep 5: 581-587.
23. Janse CJ, Waters AP 1995. Plasmodium berghei: the application of cultivation and purification techniques to molecular studies of malaria parasites. Parasitol Today 11: 138-143.
24. Jarzyna R, Kiersztan, Lisowa O, Bryla J 2001. The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action. Eur J Pharmacol 428: 381-388.
25. King J 1974. 6-Phosphogluconate dehydrogenase. In HU Bergmeyer, Methods of enzymatic analysis, Academic Press, New York, p. 632-635.
26. Kumar S, Bandyopadhyay U 2005. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188.
27. Loria P, Miller S, Folley M, Tilley L 1999. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J 339: 363-370.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall R 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
29. McCord JM, Fridovich I 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6053.
30. Mohan K, Ganguly NK, Dubey ML, Mahajan RC 1992a. Oxidative damage of erythrocyte infected with Plasmodium falciparum. An in vitro study. Ann Hematol 651: 31-134.
31. Mohan K, Ganguly NK, Dubey ML, Mahajan RC 1992b. Plasmodium falciparum induced perturbations of the erythrocyte antioxidant system. Clin Chim Acta 209: 19-26.
32. Mylonas C, Kouretas D 1999. Lipid peroxidation and tissue damage. In vivo 13: 295-309.
33. Nosál R, Jancinová V, Petríková M 1995. Chloroquine inhibits stimulated platelets at the arachidonic acid pathway. Thromb Res 77: 531-542.
34. Paglia DE, Valentine WN 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 159-164.
35. Palmen NG, Evelo CT 1998. Oxidative effects in human erythrocytes caused by some oximes and hydroxylamine. Arch Toxicol 72: 270-276.
36. Postma NS, Mommers EC, Eling WM, Zuidema J 1996. Oxidative stress in malaria: implications for prevention and therapy. Pharm World Sci 18: 121-129.
37. Radfar A, Diez A, Bautista JM 2008. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum. Free Radic Biol Med 44: 2034-2042.
38. Rodrigues JR, Gamboa ND 2009. Effects of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes. Parasitol Res 104: 1491-1496.
39. Sahni S, Saxena N, Puri S, Dutta G, Pandey V 2007. NADP-specific isocitrate dehydrogenase from the simian malaria parasite Plasmodium knowlesi: partial purification and characterization. J Euk Microbiol 39: 338-342.
40. Srivastava P, Puri SK, Kambok KK, Pandey VC 1999. Glutathione-S-transferase activity in malarial parasites. Trop Med Int Health 4: 251-254.
41. Sullivan DJ Jr, Gluzman IY, Russell DG, Goldberg DE 1996. On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci USA 93: 11865-11870.
42. Tietze F 1969. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27: 502-522.
43. Toler SM, Noe D, Sharma A 2006. Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurg Focus 21: E10.